Responsive Degradable Theranostic Agents Enable Controlled Selenium Delivery to Enhance Photothermal Radiotherapy and Reduce Side Effects
Source abstract
Abstract
Abstract Radiotherapy (RT) is a popular clinical therapy method for extending cancer patient survival, but is hampered by severe side effects and the weak therapy effect. Herein, responsive degradable selenium (Se) theranostic agents (Se@SiO2@Bi nanocomposites (NCs)) are fabricated, which combine computed tomography (CT) imaging and simultaneously enhance the therapeutic effects of photothermal therapy (PTT) and RT, while reducing the side effects of radiation. The Se@SiO2@Bi theranostic agents can accumulate at the tumor site, and responsively decompose to releease Se, avoiding systemic toxicity by the element. Se enhances the effect of PTT/RT, simultaneously reducing the side effects of RT. The Se@SiO2@Bi NCs as CT agents also exhibit significantly enhanced contrast imaging performance due to the high atomic number of Bi. More importantly, the Se@SiO2@Bi NCs can be rapidly excreted without long‐term toxicity, owing to responsive degradation into ultrasmall particles (<5 nm) at the tumor site. In vitro and in vivo results show that the Se@SiO2@Bi NCs can remarkably inhibit tumor cells, without causing appreciable toxicity during the treatment. This study opens a new perspective in rationally designing responsive degradable theranostic agents for future tumor therapy with enhanced therapeutic efficacy and lesser side effects.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence Properties of Advanced Materials · Quantum Dots Synthesis And Properties
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
College of Chemistry and Chemical Engineering Shanghai University of Engineering Science Shanghai 201620 China
Putuo Hospital Shanghai University of Traditional Chinese Medicine No. 164, Lanxi Road, Putuo District Shanghai 200062 China
Trauma Center Shanghai General Hospital Shanghai Jiaotong University School of Medicine No. 650, Xin Songjiang Road Shanghai 201620 China
Funding
National Natural Science Foundation of China
References (60)
Show source-provided references
1. 10.1039/C9CS00283A10.1039/C9CS00283A ↗
2. 10.1002/adhm.20190169510.1002/adhm.201901695 ↗
3. 10.1021/acsnano.9b0789810.1021/acsnano.9b07898 ↗
4. 10.1039/C8TB02189A10.1039/C8TB02189A ↗
5. 10.1016/j.cej.2020.12503210.1016/j.cej.2020.125032 ↗
6. 10.1016/j.biomaterials.2019.11928210.1016/j.biomaterials.2019.119282 ↗
7. 10.1039/C9BM02014D10.1039/C9BM02014D ↗
8. 10.1016/j.cej.2019.12272010.1016/j.cej.2019.122720 ↗
9. 10.1021/acsnano.7b0047610.1021/acsnano.7b00476 ↗
10. 10.1016/j.biomaterials.2020.11983510.1016/j.biomaterials.2020.119835 ↗
11. 10.1002/smll.20200043610.1002/smll.202000436 ↗
12. 10.1016/j.cej.2019.12217210.1016/j.cej.2019.122172 ↗
13. 10.1016/j.cej.2020.12445010.1016/j.cej.2020.124450 ↗
14. 10.1016/j.jcis.2018.07.00110.1016/j.jcis.2018.07.001 ↗
15. 10.1002/adma.20190499710.1002/adma.201904997 ↗
16. 10.1039/D0BM00623H10.1039/D0BM00623H ↗
17. 10.1002/anie.20200300410.1002/anie.202003004 ↗
18. 10.1021/acsami.9b1696210.1021/acsami.9b16962 ↗
19. Pasi F. · Anticancer Res. · 2010 · 30 · 2769
20. 10.1021/nn502325j10.1021/nn502325j ↗
21. 10.1016/j.freeradbiomed.2018.05.06710.1016/j.freeradbiomed.2018.05.067 ↗
22. 10.1016/j.biomaterials.2016.10.02810.1016/j.biomaterials.2016.10.028 ↗
23. 10.1002/adma.20180573010.1002/adma.201805730 ↗
24. 10.1002/anie.20151059710.1002/anie.201510597 ↗
25. 10.1002/anie.20170712810.1002/anie.201707128 ↗
26. 10.7150/thno.719310.7150/thno.7193 ↗
27. 10.1039/C7NR09237G10.1039/C7NR09237G ↗
28. 10.1016/j.biopha.2018.12.14610.1016/j.biopha.2018.12.146 ↗
29. 10.1016/j.biomaterials.2018.08.06510.1016/j.biomaterials.2018.08.065 ↗
30. 10.2147/IJN.S15754110.2147/IJN.S157541 ↗
31. 10.1002/adma.20190756810.1002/adma.201907568 ↗
32. 10.1007/BF0282001510.1007/BF02820015 ↗
33. Lee S. M. · Hell. J. Nucl. Med. · 2017 · 20 · 62
34. 10.1016/j.cca.2006.05.02110.1016/j.cca.2006.05.021 ↗
35. 10.1021/acsami.8b2267810.1021/acsami.8b22678 ↗
36. 10.1002/adhm.20190040610.1002/adhm.201900406 ↗
37. 10.1002/anie.20191445310.1002/anie.201914453 ↗
38. 10.1016/j.biomaterials.2020.12005410.1016/j.biomaterials.2020.120054 ↗
39. 10.1016/j.biomaterials.2019.05.03110.1016/j.biomaterials.2019.05.031 ↗
40. 10.1016/j.xcrp.2020.10011110.1016/j.xcrp.2020.100111 ↗
41. 10.1016/j.colsurfb.2018.03.01810.1016/j.colsurfb.2018.03.018 ↗
42. 10.1038/nbt.333010.1038/nbt.3330 ↗
43. 10.1016/j.jcis.2019.06.06610.1016/j.jcis.2019.06.066 ↗
44. 10.1002/adma.20170126810.1002/adma.201701268 ↗
45. 10.1002/adfm.20170201810.1002/adfm.201702018 ↗
46. 10.1021/nn203293t10.1021/nn203293t ↗
47. 10.1039/C5DT00198F10.1039/C5DT00198F ↗
48. 10.1016/j.biomaterials.2017.10.04810.1016/j.biomaterials.2017.10.048 ↗
49. 10.1021/nl504537810.1021/nl5045378 ↗
50. 10.1016/j.biomaterials.2012.03.02010.1016/j.biomaterials.2012.03.020 ↗
51. 10.1016/j.biomaterials.2018.10.01610.1016/j.biomaterials.2018.10.016 ↗
52. 10.1021/acs.bioconjchem.8b0024710.1021/acs.bioconjchem.8b00247 ↗
53. 10.1039/C9DT04867G10.1039/C9DT04867G ↗
54. 10.1021/acsnano.6b0665110.1021/acsnano.6b06651 ↗
55. 10.1021/acsnano.8b0328510.1021/acsnano.8b03285 ↗
56. 10.1002/adma.20180057210.1002/adma.201800572 ↗
57. 10.1002/adma.20160552910.1002/adma.201605529 ↗
58. 10.1002/adma.20190051410.1002/adma.201900514 ↗
59. 10.1039/C9BM01495K10.1039/C9BM01495K ↗
60. 10.1016/j.biomaterials.2019.11965610.1016/j.biomaterials.2019.119656 ↗